US Stock MarketDetailed Quotes
CNBX CNBX Pharmaceuticals
- 0.010200
- +0.001050+11.48%
15min DelayClose Nov 22 16:00 ET
317.34KMarket Cap0.03P/E (TTM)
0.010500High0.009150Low70.30KVolume0.009150Open0.009150Pre Close707.25Turnover0.23%Turnover RatioLossP/E (Static)31.11MShares0.01990052wk High-0.13P/B309.93KFloat Cap0.00500052wk Low--Dividend TTM30.39MShs Float27.960000Historical High--Div YieldTTM14.75%Amplitude0.005000Historical Low0.010000Avg Price1Lot Size
About CNBX Pharmaceuticals Company
CNBX Pharmaceuticals, Inc. is a clinical stage company, which engages in the discovery, development, and commercialization of cannabinoid-based products and technologies for the treatment of cancer. Its products include Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome (CACS), and RCC-33, an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC). The company was founded by Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.
Company Profile
SymbolCNBX
Company NameCNBX Pharmaceuticals
Founded2004
MarketPink Market
Employees3
Fiscal Year Ends08-31
AddressNo. 3 Bethesda Metro Center,Suite 700
CityBethesda
ProvinceMaryland
CountryUnited States of America
Zip Code20814
Phone1-877-424-2429
Websitehttp://www.cnbxpharma.com
Company Executives
- Name
- Position
- Salary
- Eyal Barad
- Chief Executive Officer and Director
- --
- Dr. Sanja Goldberg
- Chief Technology Officer
- --
- Uri Ben-Or
- Chief Financial Officer
- --
- Gabriel Yariv
- Executive Chairman of the Board
- --
- Dr. Inbar Maymon-Pomeranchik
- Independent Director
- --
- Dr. Gil Feiler
- Head of Advisory Board and Independent Director
- --
- Shaul Yemal
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
